948-03-8Relevant articles and documents
Structural insight into the anion-water cluster: Stabilised by alcohol and carboxylic acid containing tripodal ligand
Hoque, Md. Najbul,Basu, Arghya,Das, Gopal
, p. 392 - 402 (2014)
A new flexible N-bridged, unsymmetrical, water-soluble tripodal ligand (L) bearing alcohol and carboxylic acid groups has been synthesised and its solid-state interaction with anions has been investigated. The fully deprotonated ligand encapsulates a sodium cation in a half cryptand bowl-shaped cavity (1). The chloride complex 2, contains a cyclohexane-like water cluster incorporating ligand OH groups. However, complexes with bromide and nitrate (3 and 4) are dimeric. Tetrahedral clusters containing two water molecules and two anions were found in complexes 3 and 4. Perchlorate complex 5 forms perchlorate-methanol adducts. Complex 1 forms a hydrophilic cation-water channel and complexes 2-4 form anion-water channels between the hydrophobic layers of the naphthalene moieties. Complexes 2, 5 and 3, 4 are isostructural in nature having similar packing structures.
Fluorescence turn on sensor for sulfate ion in aqueous medium using tripodal-Cu2+ ensemble
Hoque, Md. Najbul,Basu, Arghya,Das, Gopal
, p. 411 - 416 (2014)
We report the selective recognition of sulfate anion in aqueous medium at biological pH 7.2 over the other interfering anions based on naphthoic acid bearing tripodal ligand by applying fluorescence turn off-on mechanism. The carboxylic acid groups in the ligand enhance the solubility in water and enable it to form complex with copper salt. Thus formed L-Cu2+ ensemble quench the fluorescence of the parent ligand and in turn recognize sulfate anion via revival of fluorescence intensity. The 1:2 stoichiometry was confirmed by ESI mass spectral data and Job's plot. The average binding constant was found to be 6.2∈×∈108 M-2. [Figure not available: see fulltext.]
CFTR-MODULATING ARYLAMIDES
-
Page/Page column 69; 70; 71, (2021/06/11)
The present disclosure relates to heterocyclic compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.
Condensed fluorene derivative comprising heterocyclic ring
-
Paragraph 0529-0535, (2019/12/25)
The present invention relates to a condensed fluorene derivative comprising a heterocyclic ring and, more particularly, to an intermediate product for manufacturing a heterocyclic ring compound which can show excellent luminance and luminous efficiency when used as an organic light emitting material, while exhibiting excellent element characteristics with a long lifespan.COPYRIGHT KIPO 2020